The regulation of integrin function by divalent cations

Cell Adhesion & Migration 6:1, 20–29; January/February 2012;

G

2012 Landes Bioscience

The regulation of integrin function by divalent cations Kun Zhang and JianFeng Chen* State Key Laboratory of Cell Biology; Institute of Biochemistry and Cell Biology; Shanghai Institutes for Biological Sciences; Chinese Academy of Sciences; Shanghai, China

Keywords: integrin, divalent cations, affinity, MIDAS, ADMIDAS, SyMBS Abbreviations: MIDAS, metal ion-dependent adhesion site; ADMIDAS, adjacent to MIDAS; SyMBS, synergistic metal ion-binding site; LIMBS, ligand-associated metal binding site; SDL, specificity-determining loop Integrins are a family of a/b heterodimeric adhesion metalloprotein receptors and their functions are highly dependent on and regulated by different divalent cations. Recently advanced studies have revolutionized our perception of integrin metal ion-binding sites and their specific functions. Ligand binding to integrins is bridged by a divalent cation bound at the MIDAS motif on top of either a I domain in I domaincontaining integrins or b I domain in a I domain-less integrins. The MIDAS motif in b I domain is flanked by ADMIDAS and SyMBS, the other two crucial metal ion binding sites playing pivotal roles in the regulation of integrin affinity and bidirectional signaling across the plasma membrane. The b-propeller domain of a subunit contains three or four b-hairpin loop-like Ca2+-binding motifs that have essential roles in integrin biogenesis. The function of another Ca2+-binding motif located at the genu of a subunit remains elusive. Here, we provide an overview of the integrin metal ion-binding sites and discuss their roles in the regulation of integrin functions.

such as talin, through a process termed inside-out signaling.8-13 Moreover, ligand occupancy can induce integrin conformational change and transduce extracellular signals into cytoplasm through outside-in signaling.9,14 Integrin-mediated adhesion and signaling events are important in normal physiological responses including immune response, tissue morphogenesis, wound healing, hemostasis, cell survival and cell differentiation.15-18 Conversely, dysregulation of integrins are involved in the pathogenesis of many diseases, including cancer metastasis, auto-immune disease and thrombotic vascular diseases.15,19-21

© 2012 Landes Bioscience. Do not distribute. Introduction Integrins are a major family of cell surface-adhesion receptors that are expressed in all metazoans. In vertebrates, 18 a subunits and 8 β subunits have been discovered, which combine into 24 different heterodimers that recognize overlapping but distinct sets of extracellular ligands (Fig. 1).1,2 As adhesion molecules, integrin can mediate cell-cell, cell-matrix and cell-pathogen interactions.3-7 Most integrins are not constitutively active and often expressed on cell surface in an inactive state, in which they neither bind ligands nor signal. The basal low adhesiveness of integrins is very important for their biological functions, such as integrins on circulating blood cells. There are around 1 mM Ca2+ and Mg2+ in blood and the existence of Ca2+ play an important role in keeping integrins in inactive state. Removal of Ca2+ or addition of Mn2+ will strikingly increase ligand binding affinity and adhesiveness of almost all integrins. In addition to extracellular divalent cations, integrin can also be activated by intracellular proteins or stimuli, *Correspondence to: JianFeng Chen; Email: [email protected] Submitted: 09/30/11; Revised: 11/03/11; Accepted: 11/08/11 http://dx.doi.org/10.4161/cam.18702

20

Integrin Overall Structure and Conformational Changes Associated with Affinity Regulation

Integrins are type I trans-membrane proteins with large ectodomains, short trans-membrane and cytoplasmic domains (except for β4 subunit with exceptional long cytoplasmic domain of ~1,000 amino acids) (Fig. 2).22 There are four extracellular domains, β-propeller, thigh, calf-1 and calf-2, present in all a subunits (Fig. 2). In addition, half of the a subunits incorporate an additional autonomous folding domain of ~200 amino acids termed the inserted domain (I domain) (Figs. 1 and 2).23,24 Thus, integrins can be classified into two subfamilies, the a I-containing integrins and a I-less integrins. The β subunit ectodomain contains eight domains, β I domain, hybrid, PSI, β-tail and four integrin-EGF domains (Fig. 2). Electron microscopy and X-ray crystal structure studies of several integrins (e.g., aIIbβ3, aVβ3, aXβ2) have demonstrated independently that the overall shape of integrin ectodomain is that of a large “head” on two long “legs” with flexible “knees” (Fig. 2B and C).25-28 The a head is composed of β-propeller domain and a I domain in a I-containing integrins, while a single β-propeller forms a head in a I-less integrins (Fig. 2B and C). The β I domain, sharing the same overall fold as the a I domain, is present in all β subunits and forms β head (Fig. 2B and C). a I domain is the ligand binding domain in a I-containing integrins whereas the β I domain forms a major ligand binding pocket in a I-less integrins (Fig. 2B and C).29-31 Integrin affinity regulation is highly related to its global and local conformational rearrangements. It has been demonstrated that integrins exist in at least three conformational states: the bent conformation with closed headpiece, the extended conformation with closed headpiece and the extended

Cell Adhesion & Migration

Volume 6 Issue 1

SPECIAL FOCUS REVIEW: CAMS AND STEM CELLS

Figure 1. Integrin family. Integrins are loosely grouped into three classes that bind basal extracellular matrix (ECM), provisional ECM and cell surface adhesion molecules (CAMs), respectively. Basal ECM mainly includes collagen and laminin. Provisional ECM mainly includes fibrinogen, fibronectin, vitronectin, cryptic collagen and von Willebrand factor. The a I-containing integrins are asterisked.

identified two functionally distinct classes of metal ion-binding sites in β3.50 One site is capable of binding Ca2+, Mg2+ and Mn2+, and is required for integrin-ligand binding, whereas the other site is specific for Ca2+ and has an inhibitory effect for ligand binding.50 Three kinds of binding sites for Ca2+ have been identified in a4β1, which differ in Ca2+-binding affinity.51 The first kind is a moderate-affinity site (ED50 50–100 mM) that only can be rapidly occupied after integrin binds ligand; the second kind is a ligand binding-independent high-affinity site (ED50 20 mM); the third kind has the low-affinity for Ca2+ and its occupancy can inhibit integrin-ligand binding.51 Integrin crystal structures have provided new insights into the metal ion-binding sites, and their functions are further revealed by mutagenesis studies. To date, eight divalent cation binding sites have been discovered in integrin ectodomains with five in a subunit and three in β subunit (Fig. 2). The following part will give a general review on integrin divalent cation binding sites. a Subunit b-Propeller Ca2+-Binding Sites

© 2012 Landes Bioscience. conformation with open headpiece, which are corresponding to the low-, intermediate- and high-affinity states, respectively (Fig. 2B and C).12 Correspondingly, it is proposed that integrin activation is accompanied with a switchblade-like opening of the headpiece-tailpiece interface, which extends the ligand-binding headpiece of the integrin heterodimer away from the plasma membrane (Fig. 2B and C).12 Cell surface integrins are in the equilibrium among these conformational states which can be shifted by certain stimuli, such as extracellular metal ions. Divalent cations are essential for integrin functions, from stabilizing integrin structure to mediating its interaction with the ligand and modulating integrin-ligand binding in either an enhancing or a suppressing way.32-40 The removal of divalent cations by EDTA completely inhibits integrin-ligand binding. And the formation of integrin heterodimer complex is also dependent on the presence of at least micromole levels of divalent cations.33-40 Physiologically, most integrins are in the resting state with the presence of 1 mM Ca2+ and 1 mM Mg2+ in body fluid. The millimole level Ca2+ often has an inhibitory effect on integrin-ligand binding.38,41-47 By removal of Ca2+, the remaining Mg2+ alone can promote ligand binding in most integrins. Studies also indicate that micromolar Ca2+ can synergize with suboptimal concentration of Mg2+ to further activate integrins.38,41-47 As a non-physiological stimulus, Mn2+ can shift integrins into highaffinity conformations (detected by special activation-dependent mAbs) and strikingly activate integrins, even with the presence of millimolar Ca2+.38,41-47 The preliminary information on integrin metal ion-binding sites was obtained from equilibrium dialysis and Tb3+ luminescence assay using purified integrin fragments, demonstrating that there are at least five divalent cation binding sites in aIIbβ3.48,49 Further studies using recombinant integrin fragments

The N-terminal region of integrin a subunit comprises seven homologous repeats of ~60 residues which fold into a 7-bladed β-propeller domain.28 Two concentric rings of predominantly aromatic residues, which line the upper, inner rim of the propeller core, build up a “cage” motif (Fig. 3C).52 Each blade is composed of four anti-parallel β-strands, adopting a “W” topology (Fig. 3D).28 Loops connecting the strands extend either above or below the plane of the propeller (Fig. 3B and D).52 There are three to four Ca2+-binding sites located in the first loops extending between propeller blades 4 to 7 (Fig. 3A and B).28 The Ca2+binding domains were originally described as resembled similar to EF hand structures, but recent computer modeling data and the crystal structures of aVβ3 and aIIbβ3 indicate that these domains are β-hairpin loops, consisting of a charged loop with a glycine hinge, flanked by groups of hydrophobic residues.28,52-55 The Ca2+binding sites span a nine-residue segment with the consensus sequence Asp/Glu-h-Asp/Asn-x-Asp/Asn-Gly-h-x-Asp/Glu where “h” is hydrophobic and “x” is any residue.28 Ca2+ is usually coordinated by oxygen atoms from side chains of residues 1, 3, 5 and 9 and the carbonyl oxygen of residue 7 (Fig. 3A).28 These Ca2+-binding sites are located at the bottom β-propeller, opposite to the integrin a/β subunits interface (Fig. 3B), and are unlikely to be accessed by large ligands in intact integrins on cell surface although the synthetic or recombinant fragments containing these calcium binding sites have been reported to bind integrin ligands.56,57 But together with the N-terminal one-third region of β-propeller, those Ca2+-binding sites have been shown to involve in the determination of ligand-recognition specificity in aIIbβ3.58 Substitution of the N-terminal portion of aV with the homologous fragment from aIIb endows aVβ3 with the reactivity to aIIbβ3 small ligands and its specific ligand mimetic antibodies.58 Moreover, the β-propeller Ca2+-binding sites also involve in the regulation of integrin-ligand binding affinity since conservative mutations in those sites of a4 β-propeller significantly decreased the affinity of ligand binding to a4β1.59

Do not distribute.

www.landesbioscience.com


21

Figure 2. Schematic of integrin structure and conformational rearrangements. (A) Organization of domains within the primary structure. a I domain inserted in b-propeller is denoted by dash lines. Yellow and red asterisks denote Ca2+and Mg2+-binding sites, respectively. Open asterisk denotes the Ca2+-binding site in the forth repeat of b-propeller domain in some a subunits. (B and C) Conformational rearrangements of a I-containing (B) and a I-less integrins (C) during activation.

Another important function of the βpropeller Ca2+-binding sites is that they are essential to integrin biogenesis by facilitating the early folding process of aIIb and conferring stability to the cage motif during aIIbβ3-herterodimer formation.52 Seven mutations either in or near the aIIb βpropeller Ca2+-binding sites have been found in patients who suffer from Glanzman thrombsthenia, an inherited platelet disorder, including Gly242Asp from W4, Val298Phe, Glu324Lys, and Arg327His from W5, Ile374Thr from W6, and Gly418Asp and deletion Val425/Asp426 from W7 (Fig. 3D).52,60-64 All of these mutations resulted in defective Ca2+ binding by either directly interfering with Ca2+ coordination or disrupting the electrostatic potential conductive to Ca2+ binding. Consequently, β-propeller can’t be folded properly and the stability of the integrin a/β interface will be jeopardized. Furthermore, the malfolded heterodimer will be largely retained within the endoplasmic reticulum and cannot be efficiently transported to Golgi.52,60-64

© 2012 Landes Bioscience. Do not distribute.

a Subunit Genu Ca2+-Binding Site There is one Ca2+-binding site located at a subunit genu, which linking thigh domain and calf-1 domain and where the a subunit sharp bending occurs in bent conformation. The epitopes of two Ca2+-dependent antibodies that can detect the extention of aL subunit have been mapped to this region and the occupancy of genu Ca2+-binding site is required for the binding of the antibodies.65 Further mutational studies indicate that genu Ca2+-binding site is occupied in integrins in both bent and extended conformations.65 Coordinations to genu Ca2+ in aIIb are formed by the backbone carbonyl of Cys602 and Val607, the side chain of Asp605 in genu, and the side chain of Glu642 in Calf-1.27 As the acidic patches of the thigh

22


Volume 6 Issue 1

base and that of the calf-1 top will face each other in the extended integrin, it was speculated that a well-coordinated genu Ca2+ may help stabilize the extended conformation of high-affinity integrin by neutralizing the negative charge at this interface.28 However, the clear-cut biological function of genu Ca2+-binding site remains elusive.

a I Domain MIDAS The a I domain, which is inserted between blade 2 and 3 of β-propeller, is the ligand binding domain in a I-containing integrins.55,66,67 The a I domain adopts the dinucleotide-binding Rossmann fold, with the gradually decreased affinity for metal


Figure 3. Ca2+-binding sites in a subunit b-propeller domain. (A) Sequence alignment of the Ca2+-binding sites in b-propeller domain of 18 human a subunits. The a subunits containing a I domain are asterisked. Residues with metal-coordinating side-chain oxygen atoms are highlighted in red, and residues with metal-coordinating backbone carbonyl oxygen atoms are highlighted in deep purple. The residue numbers are shown in light blue on the left of the first residue of each Ca2+ binding sequence. (B) Side-view of the unliganded crystal structure of aIIbb3 headpiece (pdb3FCS), with aIIb subunit shown in green and b3 in blue. The aIIb b-propeller bound Ca2+ ions are denoted in yellow spheres. (C) Schematic of the aIIb b-propeller domain showing the central cage motif (top view).52 (D) Schematic of the “W” topology of blade 4 (side view) in aIIb b-propeller domain. The relative locations of the seven mutations found in Glanzmann thrombasthenia patients are shown. The mutant residues are shown in small red spheres and the bound Ca2+ are shown in a large yellow sphere.



23

ions in the order of Mn2+ . Mg2+ . Ca2+.9,23 Structural studies revealed a metal ion-binding site located on the top face of a I domain (Fig. 4A).9,32 As the metal ion at this site directly coordinates the side chain of an acidic residue that is characteristic of all integrin ligands, it has been designated as the metal iondependent adhesion site (MIDAS).9,68,69 The MIDAS metal ion is coordinated by five side chains from three different loops. The β1-a1 loop contains three coordinating residues in a sequence of the characteristic cation-binding site, Asp-X-Ser-XSer (Fig. 4B and C).9 The a3-a4 and β4-a5 loops donate the other two coordinating residues of Thr and Asp, respectively (Fig. 4B and C).9 The aM I domain has been crystallized in three distinct conformations, termed closed, intermediate, and open, which are corresponding to the low, intermediate and high ligandbinding affinities.68,70-72 These conformations demonstrate distinct patterns of MIDAS metal ion coordination. In both closed and open aM I domains, the MIDAS metal ion shares the primary coordinating residues of Ser142, Ser144 and secondary coordinating residue of Asp140 in β1-a1 loop (Fig. 4B and C). In the closed conformation, Thr209 in a3-a4 loop and Asp242 in β4-a5 loop form indirect and direct bonds to MIDAS metal ion, respectively, and three water molecules completes the coordination sphere (Fig. 4B).9,32 In the open structure, the metal ion moves by ~2.3 Å, resulting in a subtle change in its coordination: Thr209 now coordinates the MIDAS metal ion directly, whereas Asp242 is in the secondary coordination sphere (Fig. 4A–C). Moreover, a Glu, contributed by the ligand, replaces one water molecule at the sixth metal ion coordination site (Fig. 4C).9 Further studies using surface plasmon resonance suggested an inverse relationship between the affinity of a I domain for metal ions and the affinity for ligand, that is the closed conformation exhibits the highest affinity for metal ions.23 Compared with the closed conformation, the local changes at the MIDAS face induce downward displacement of C-terminal a7-helix by two helical turns in open conformation (Fig. 4A).73,74 The axial displacement of the a7-helix represents a critical linkage for transmission of conformational signals from the MIDAS of a I domain to other integrin domains, and vice versa, especially for the allosteric regulation from β I domain, which will be discussed later.9,32,73,74 For many integrins, millimolar Ca2+ often has an inhibitory effect on ligand binding.38,41,42,75 Hypothesis has been proposed that high concentration of Ca2+ may compete with Mg2+/Mn2+ for a I domain MIDAS occupancy in a I-containing integrins.46 However, the hypothesis disagrees with some studies. For example, high concentration Ca2+ does not inhibit ligand binding to the isolated a2 I domain.44,46 Since the MIDAS motif is in a coordination geometry that the larger calcium ion is predicted not to bind, the high concentration Ca2+ may exert the inhibitory function in other Ca2+-binding sites, probably in β I domain.44,70,71

fold as a I domain, with a central six-stranded β sheet surrounded by eight helices.28 Different from a I domain with only one MIDAS site, β I domain contains an interlinked linear array of three metal ion-binding sites, with MIDAS at the center and flanked by two other sites: the synergistic metal ion-binding site (SyMBS) and adjacent to MIDAS (ADMIDAS) (Fig. 4D– G).27,28,68,70,73,77-83 Only ADMIDAS is occupied by metal ion in the crystal structure of unliganded aVβ3, whereas both MIDAS and SyMBS are also found occupied by Mn2+ in the ligandedaVβ3 crystal structure.28,73 Thus, SyMBS is previously termed as ligand-associated metal binding site (LIMBS).73 Differently, in the unliganded aIIbβ3 crystal structure, all of the three metal ionbinding sites are occupied when physiologic divalent cations, Ca2+ and Mg2+, are present (Fig. 4D–F).27 Electron density in crystal structures suggests that MIDAS is occupied by Mg2+ and the two flanking sites are loaded with Ca2+ (Fig. 4D–F).27 Comparable to a I domain, β I domain C-terminal a7-helix proceeds a similar downward displacement in the transition from low- to highaffinity and allosterically alters the geometry of the metal ion clusters in a way to increase the affinity for ligand binding (Fig. 4).12,84 And this process is coupled to the outward swing of the hybrid domain relative to β I domain (Fig. 2B and C).12,84 β I domain MIDAS. Similar to a I domain MIDAS, the β MIDAS also contains a conservative Asp-X-Ser-X-Ser motif, which is essential to coordinating the metal ion and subsequent ligand binding.28 The overall geometry of metal-ion coordination is similar to that of a I MIDAS, e.g., the β3 MIDAS is formed by the side chains of Asp119, Ser121, Ser123, Glu220 and Asp251 (Fig. 4E and F). Removal of MIDAS metal ion by mutations completely abolished ligand binding, demonstrating its essential role in integrin-ligand binding in both a I-containing and a I-less integrins.30,73,79 Crystal structures of β3 integrins have revealed that the carboxyl group of Asp in the RGD sequence of ligand coordinates with the MIDAS Mg2+ of β subunit during ligand binding.73 Although there is no lateral movement of the MIDAS metal ion across the ligand-binding pocket in the transition from low- to high-affinity state of β I domain, the movement of β1-a1 loop and its bound ADMIDAS Ca2+ toward the MIDAS Mg2+ will make MIDAS more electrophilic for the acidic ligand residue (Fig. 4E and F).27,28 For a I-containing integrins, the β MIDAS does not directly mediate ligand binding. It is proposed that an invariant Glu (Glu310 in aL), in the linker between the C-terminal a7-helix and β3-sheet of the β-propeller, can bind to the activated a I domain MIDAS as an intrinsic ligand (Fig. 2B).9,85-87 Therefore, the activation signal can be transferred from β I to a I domain through this intrinsic interaction and induce the activation of a I domain by exerting a downward pull on the a7 helix in a I domain (Fig. 2B). Broken of this intrinsic interaction by mutation of Glu310 in aL inhibits integrin aLβ2 activation.85-87 By contrast, constitutive linkage of aL I domain a7-helix with β2 MIDAS-loop by an inter-subunit disulfide bond can induce aLβ2 activation.87 β I domain ADMIDAS. Based on structural and mutagenesis studies, it is proposed that ADMIDAS is the negative regulatory site responsible for inhibition of integrin activation by high


b I Domain Metal Ion Cluster β I domain directly binds ligand in a I-less integrins and allosterically regulates a I domain mediated ligand binding in a Icontaining integrins.68,76 β I domain assumes a similar Rossmann

24


Volume 6 Issue 1


Figure 4. Structural rearrangements of integrin a/b I domains and their metal ion-binding sites. (A–C) aM I domain and MIDAS. (A) Superposition of integrin aM I domains in low-affinity (pdb1JLM, cyan) and high-affinity (pdb1IDO, green) conformations. Blue and red spheres denote the MIDAS metal ions in low- and high-affinity conformations, respectively. (B and C) MIDAS from the closed (pdb1JLM) (B) and open (pdb1IDO) (C) aM I domains. The metal ion coordinations are shown by red dashed lines. Glu314 from a neighboring aM I domain in crystal lattice coordinates with the MIDAS Mg2+ and is shown in yellow. Large blue and red spheres are Mn2+ and Mg2+, respectively, and small red spheres are coordinating water-molecule oxygens. (D–F) b3 I domain and its metal ion cluster. (D) Superposition of b subunit I domains from integrin aIIbb3 in low-affinity (pdb3FCS, cyan) and high-affinity (pdb3FCU, green) conformations. Blue and red spheres denote Mg2+ in low- and high-affinity MIDAS, respectively. Orange and yellow spheres denote Ca2+ in low- and high-affinity b I domains, respectively. (E) Structure of low-affinity b3 metal ion-binding sites (pdb3FCS). (F) Structure of high-affinity b3 metal ion-binding sites (pdb3FCU). (G) Structure of metal ion-binding sites in low-affinity b2 (pdb3K6S). The linear cluster of b I domain metal ion-binding sites are shown as SyMBS, MIDAS and ADMIDAS from left to right. The metal ion-binding sites are colored as follows: yellow, SyMBS; pink, MIDAS; purple-blue, ADMIDAS. Mg2+ ions in low- and high-affinity MIDAS are shown as large blue and red spheres, respectively. The SyMBS and ADMIDAS bound Ca2+ ions are shown as large yellow spheres. Coordinating water-molecule oxygens are shown as small red spheres. N and O atoms involved in metal ion-coordinating are colored in blue and red, respectively. Coordinations between O atoms and metal ions are shown by red dashed lines. The cation-p interaction between the aromatic side chain of Y164 (in b3) and SyMBS metal ion is shown by blue dashed line.



25

concentration of Ca2+ and Mn2+ competes with Ca2+ at this site to activate integrin.28,73,79 In the unliganded low-affinity crystal structure of β3 integrin, the ADMIDAS Ca2+ coordinates with the backbone carbonyl oxygen of Met335 in β6-a7 loop (Fig. 4E).27 This interaction restrains the downward movement of β I domain a7-helix and stabilizes integrin in the closed conformation. By contrast, in the liganded high-affinity β3 structure, the Met335 coordination is broken with the downward displacement of a7helix and the side-chain carboxyl of the Asp251 forms a new direct coordination with the ADMIDAS ion (Fig. 4F).73 Loss of the Met335 carbonyl coordination is favored by substitution of Ca2+ by Mn2+, because Ca2+ but not Mn2+ has a strong propensity to coordinate carbonyl oxygen atom.88 Furthermore, the movement of Asp251 toward ADMIDAS makes the MIDAS more positive, resulting in higher affinity for integrin ligands.27 However, ADMIDAS mutagenesis studies on different integrins produced conflicting effects on ligand binding. For integrins a4β7 and aLβ2 that can mediate both rolling and firm cell adhesions prior- and post-activation, removal of metal ion occupancy at ADMIDAS by mutating its coordination residues induced integrin activation.79,80,89 Whereas for integrins that can only mediate firm cell adhesion upon activation, e.g, a5β1, a2β1 and aIIbβ3, ADMIDAS mutations decreased ligand binding.31,78,81,90 Sequence alignment reveals a potential residue that may contribute to the differences. Following the Asp242 (in β2), there is a second Asp in β2 and β7 instead of an Ala in β1 and β3 (Fig. 4E–G). Recently solved aXβ2 crystal structure shows that the second Asp (Asp243) in β2 is close to MIDAS, and has the potential to coordinate MIDAS metal ion in low-affinity β I domain (Fig. 4G).25 Thus, the MIDAS of β2 and β7 is more negative than that of β3 and β1, resulting in a lower affinity for ligand binding. During integrin activation, Asp243 in β2 will move toward the ADMIDAS along with the anterior Asp242, which will reduce the negativity of MIDAS and lead to higher affinity for ligands. Thus, it is speculated that the previously reported β2 and β7 ADMIDAS mutations do not abolish the ADMIDAS metal ion binding, but instead, induce the shift of the two adjacent Asp residues toward ADMIDAS to fulfill the ADMIDAS metal ion coordination, and resulted in a more positive MIDAS which is able to bind ligands with higher affinity than WT.78 Despite of the distinct roles in affinity regulation in different integrins, ADMIDAS mutations in all integrins abolished integrin allosteric conformational changes and outside-in signaling.78,91 All ADMIDAS mutants are in bent conformation with clasped a/β tails, even for the high-affinity β2 and β7 ADMIDAS mutants.91 Therefore, ADMIDAS plays an important role in linking β I domain and hybrid domain, most likely through the interaction with Met335 (in β3) in the β6-a7 loop, for the propagation of integrin conformational changes and signaling. The in vivo function of ADMIDAS was studied using integrin β7 knock-in mice with β7 ADMIDAS mutation D146A, which disrupted the divalent cation binding at ADMIDAS.92 Similar to the results obtained from the in vitro study,79 the ADMIDAS mutation enhanced the lymphocytes adhesion to a4β7 ligand MAdCAM-1 and perturbed lymphocytes migration on MAdCAM-1 substrates in vitro.92 Although the

ADMIDAS mutation enhanced lymphocytes adhesion to Peyer’s patch venules in vivo, it suppressed the subsequent homing to gut.92 Additionally, the disabled β7 ADMIDAS diminished the capacity of T cells to induce colitis.92 Thus, ADMIDAS is indispensable for integrin a4β7 mediated lymphocyte homing to gut and trafficking to the inflammation sites. β I domain SyMBS. SyMBS is the positive regulatory site for integrin-ligand binding. Mutations at SyMBS abolished ligand binding in a2β1, a5β1, aIIbβ3 and aLβ2 integrins, and converted a4β7-mediated high-affinity firm adhesion into lowaffinity rolling adhesion in shear flow,79-81,83,91,93-96 which demonstrate that integrin activation is dependent on the occupancy of metal ion at SyMBS. In addition, SyMBS metal ion can form a cation-p interaction with a conserved aromatic residue (Tyr or Phe) in the specificity-determining loop (SDL) (Fig. 4E–G), which may help to stabilize SyMBS metal ion coordination and maintain the proper conformation of SDL.97 The disruption of this interaction abolished a4β7-MAdCAM-1 high-affinity binding.97 SyMBS is important but not absolutely required for integrin activation since the negative effect of SyMBS mutations on integrin-ligand binding can be counteracted by mutations that stabilize integrins in high-affinity conformations.31,78,80,91,98,99 Synergy between MIDAS and SyMBS. In contrast to the inhibitory effect of high concentration (millimole level) of Ca2+, low concentration (micromole level) of Ca2+ can synergize with suboptimal concentrations of Mg2+ to facilitate ligand binding has been discovered in various integrin families.31,41,44,50,75,79,80,100-104 For example, low concentration of 50 mM Ca2+ greatly augmented a4β7-mediated adhesion in 50 mM Mg2+.79 Since MIDAS has the propensity to bind Mg2+, Ca2+ is more likely to exert the positive synergistic effect though either SyMBS or ADMIDAS which prefers Ca2+ to Mg2+. Mutagenesis studies suggested that the synergy occurred between SyMBS and MIDAS, as SyMBS mutations, but not ADMIDAS mutations, abolished the synergistic adhesion.79 aIIbβ3 crystal structures provided a possible structural basis for the synergy between MIDAS and SyMBS.27 In both the unliganded low-affinity state and liganded highaffinity state, the MIDAS Mg2+ and SyMBS Ca2+ share the sidechain carboxyl of β3 subunit Glu220 (Fig. 4E and F). Therefore, the presence of SyMBS Ca2+ may favor the specific orientation of this side-chain and stabilize MIDAS Mg2+ occupancy.27


26

Concluding Remarks The metal ion dependence of integrin function has been investigated over several decades and progresses have been made to define and locate the metal ion-binding sites and their functions. For now, it seems clear that the a subunit β-propeller have three to four metal ion-binding sites that are deemed to bind Ca2+ under physiological conditions, which are important for integrin heterodimer biogenesis and stability. There is one calcium-binding site located at genu in a subunit, but its function is still ill defined.28 Another pivotal function of divalent cations is to regulate integrin ligand-binding, which is mainly through a I domain MIDAS and β I domain metal ion cluster.9 MIDAS motif of both a I domain and β I domain prefers to bind Mg2+


Volume 6 Issue 1

under physiological conditions, and is essential for ligand binding. Ca2+ exerts the biphasic allosteric regulation function through SyMBS and ADMIDAS in β I domain. Mn2+ may activate integrins by competing Ca2+ binding at multiple metal ionbinding sites, one could be ADMIDAS, but the exact mechanism is not very clear.14,31 Furthermore, almost all the information about integrin metal ion-binding sites is obtained using purified integrins and cell lines by in vitro study, it is still largely unknown whether divalent cations can regulate integrin ligand-binding affinity in vivo or not. It was reported that extracellular Ca2+ and Mg2+ might regulate cell migration during cutaneous injury and bone resorption.42,105 During the early stages of cutaneous injury, to which the inflammatory responses are mainly mediated by integrins, the concentrations of extracellular Ca2+ and Mg2+ in References 1.

Humphries JD, Byron A, Humphries MJ. Integrin ligands at a glance. J Cell Sci 2006; 119:3901-3; PMID:16988024; http://dx.doi.org/10.1242/jcs.03098 2. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002; 110:673-87; PMID:12297042; http://dx.doi.org/10.1016/S0092-8674(02)00971-6 3. Arnaout MA. Integrin structure: new twists and turns in dynamic cell adhesion. Immunol Rev 2002; 186:125-40; PMID:12234368; http://dx.doi.org/10. 1034/j.1600-065X.2002.18612.x 4. Askari JA, Buckley PA, Mould AP, Humphries MJ. Linking integrin conformation to function. J Cell Sci 2009; 122:165-70; PMID:19118208; http://dx.doi. org/10.1242/jcs.018556 5. Caswell PT, Norman JC. Integrin trafficking and the control of cell migration. Traffic 2006; 7:14-21; PMID:16445683; http://dx.doi.org/10.1111/j.16000854.2005.00362.x 6. Huttenlocher A, Sandborg RR, Horwitz AF. Adhesion in cell migration. Curr Opin Cell Biol 1995; 7:697706; PMID:8573345; http://dx.doi.org/10.1016/ 0955-0674(95)80112-X 7. Huttenlocher A, Ginsberg MH, Horwitz AF. Modulation of cell migration by integrin-mediated cytoskeletal linkages and ligand-binding affinity. J Cell Biol 1996; 134:1551-62; PMID:8830782; http://dx. doi.org/10.1083/jcb.134.6.1551 8. Tadokoro S, Shattil SJ, Eto K, Tai V, Liddington RC, de Pereda JM, et al. Talin binding to integrin β tails: a final common step in integrin activation. Science 2003; 302:103-6; PMID:14526080; http://dx.doi.org/ 10.1126/science.1086652 9. Luo B-H, Carman CV, Springer TA. Structural basis of integrin regulation and signaling. Annu Rev Immunol 2007; 25:619-47; PMID:17201681; http://dx.doi. org/10.1146/annurev.immunol.25.022106.141618 10. Zhu J, Carman CV, Kim M, Shimaoka M, Springer TA, Luo BH. Requirement of a and β subunit transmembrane helix separation for integrin outside-in signaling. Blood 2007; 110:2475-83; PMID:17615290; http://dx.doi.org/10.1182/blood-2007-03-080077 11. Bouaouina M, Lad Y, Calderwood DA. The Nterminal domains of talin cooperate with the phosphotyrosine binding-like domain to activate β1 and β3 integrins. J Biol Chem 2008; 283:6118-25; PMID: 18165225; http://dx.doi.org/10.1074/jbc.M709527200 12. Takagi J, Petre BM, Walz T, Springer TA. Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling. Cell 2002; 110:599-611; PMID:12230977; http://dx.doi. org/10.1016/S0092-8674(02)00935-2

wound fluids are significantly different from those observed in normal extracellular fluid. Particularly, Mg2+ concentration is elevated and Ca2+ is reduced, and consequently promotes the migration of keratinocytes, macrophages, fibroblasts and endothelial cells on collagen.105 But, the mechanism underlying the regulation of cell migration by cations in vivo is still unknown. Thus, to explore the potential regulatory effects of divalent cations on integrins in vivo and their working mechanisms will be of more interest. Acknowledgments

This work was supported by grants from the National Basic Research Program of China (2010CB529703) and National Natural Science Foundation of China (30700119, 30970604).

13. Mandeville JT, Maxfield FR. Effects of buffering intracellular free calcium on neutrophil migration through three-dimensional matrices. J Cell Physiol 1997; 171:168-78; PMID:9130464; http://dx.doi. org/10.1002/(SICI)1097-4652(199705)171:2,168:: AID-JCP7.3.0.CO;2-M 14. Litvinov RI, Nagaswami C, Vilaire G, Shuman H, Bennett JS, Weisel JW. Functional and structural correlations of individual aIIbβ3 molecules. Blood 2004; 104:3979-85; PMID:15319287; http://dx.doi. org/10.1182/blood-2004-04-1411 15. Springer TA, Wang J-h. The three-dimensional structure of integrins and their ligands, and conformational regulation of cell adhesion. Adv Protein Chem 2004; 68:29-63; PMID:15500858; http://dx.doi.org/10. 1016/S0065-3233(04)68002-8 16. Bon G, Folgiero V, Di Carlo S, Sacchi A, Falcioni R. Involvement of a6β4 integrin in the mechanisms that regulate breast cancer progression. Breast Cancer Res 2007; 9:203; PMID:17319974; http://dx.doi.org/10. 1186/bcr1651 17. Di Sabatino A, Rovedatti L, Rosado MM, Carsetti R, Corazza GR, MacDonald TT. Increased expression of mucosal addressin cell adhesion molecule 1 in the duodenum of patients with active celiac disease is associated with depletion of integrina4β7-positive T cells in blood. Hum Pathol 2009; 40:699-704; PMID:19157500; http://dx.doi.org/10.1016/j.humpath. 2008.10.014 18. Varner JA, Cheresh DA. Tumor angiogenesis and the role of vascular cell integrin aVβ3. Important Adv Oncol 1996; 69-87; PMID:8791129 19. Tanaka T, Ohtsuka Y, Yagita H, Shiratori Y, Omata M, Okumura K. Involvement of a1 and a4 integrins in gut mucosal injury of graft-versus-host disease. Int Immunol 1995; 7:1183-9; PMID:7495725; http://dx. doi.org/10.1093/intimm/7.8.1183 20. Garmy-Susini B, Varner JA. Roles of integrins in tumor angiogenesis and lymphangiogenesis. Lymphat Res Biol 2008; 6:155-63; PMID:19093788; http://dx. doi.org/10.1089/lrb.2008.1011 21. von Andrian UH, Engelhardt B. a4 integrins as therapeutic targets in autoimmune disease. N Engl J Med 2003; 348:68-72; PMID:12510047; http://dx. doi.org/10.1056/NEJMe020157 22. Quinn MJ, Byzova TV, Qin J, Topol EJ, Plow EF. Integrin aIIbβ3 and its antagonism. Arterioscler Thromb Vasc Biol 2003; 23:945-52; PMID:12637342; http://dx.doi.org/10.1161/01.ATV.0000066686.46338. F1

23. Vorup-Jensen T, Waldron TT, Astrof N, Shimaoka M, Springer TA. The connection between metal ion affinity and ligand affinity in integrin I domains. Biochim Biophys Acta 2007; 1774:1148-55; PMID: 17702677 24. Berman AE, Kozlova NI. Integrins: structure and functions. Membr Cell Biol 2000; 13:207-44; PMID: 10779172 25. Xie C, Zhu J, Chen X, Mi L, Nishida N, Springer TA. Structure of an integrin with an aI domain, complement receptor type 4. EMBO J 2010; 29:666-79; PMID:20033057; http://dx.doi.org/10.1038/emboj. 2009.367 26. Xiong JP, Mahalingham B, Alonso JL, Borrelli LA, Rui X, Anand S, et al. Crystal structure of the complete integrin aVβ3 ectodomain plus an a/β transmembrane fragment. J Cell Biol 2009; 186:589-600; PMID:19704023; http://dx.doi.org/10.1083/jcb. 200905085 27. Zhu J, Luo BH, Xiao T, Zhang C, Nishida N, Springer TA. Structure of a complete integrin ectodomain in a physiologic resting state and activation and deactivation by applied forces. Mol Cell 2008; 32:849-61; PMID:19111664; http://dx.doi.org/10. 1016/j.molcel.2008.11.018 28. Xiong JP, Stehle T, Diefenbach B, Zhang R, Dunker R, Scott DL, et al. Crystal structure of the extracellular segment of integrin aVβ3. Science 2001; 294:339-45; PMID:11546839; http://dx.doi.org/10.1126/science. 1064535 29. Shimaoka M, Lu C, Palframan R, von Andrian UH, Takagi J, Springer TA. Reversibly locking a protein fold in an active conformation with a disulfide bond: integrin aL I domains with high affinity and antagonist activity in vivo. Proc Natl Acad Sci USA 2001; 98:6009-14; PMID:11353828; http://dx.doi.org/10. 1073/pnas.101130498 30. Xiao T, Takagi J, Coller BS, Wang JH, Springer TA. Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature 2004; 432:59-67; PMID:15378069; http://dx.doi.org/10. 1038/nature02976 31. Valdramidou D, Humphries MJ, Mould AP. Distinct roles of β1 metal ion-dependent adhesion site (MIDAS), adjacent to MIDAS (ADMIDAS), and ligand-associated metal-binding site (LIMBS) cationbinding sites in ligand recognition by integrin a2β1. J Biol Chem 2008; 283:32704-14; PMID:18820259; http://dx.doi.org/10.1074/jbc.M802066200




27

32. Xiong JP, Stehle T, Goodman SL, Arnaout MA. Integrins, cations and ligands: making the connection. J Thromb Haemost 2003; 1:1642-54; PMID: 12871301; http://dx.doi.org/10.1046/j.1538-7836. 2003.00277.x 33. Steiner B, Parise LV, Leung B, Phillips DR. Ca2+dependent structural transitions of the platelet glycoprotein IIb-IIIa complex. Preparation of stable glycoprotein IIb and IIIa monomers. J Biol Chem 1991; 266:14986-91; PMID:1869535 34. Jackson DE, Poncz M, Holyst MT, Newman PJ. Inherited mutations within the calcium-binding sites of the integrin aIIb subunit (platelet glycoprotein IIb). Effects of the amino acid side chain and the amino acid position on cation binding. Eur J Biochem 1996; 240:280-7; PMID:8925838; http://dx.doi.org/10. 1111/j.1432-1033.1996.0280h.x 35. Kunicki TJ, Pidard D, Rosa J-P, Nurden AT. The formation of Ca2+ dependent complexes of platelet membrane glycoproteins IIb and IIIa in solution as determined by crossed immunoelectrophoreisis. Blood 1981; 58:268-78; PMID:6454451 36. Ginsberg MH, Lightsey A, Kunicki TJ, Kaufmann A, Marguerie G, Plow EF. Divalent cation regulation of the surface orientation of platelet membrane glycoprotein IIb: Correlation with fibrinogen binding function and definition of a novel variant of Glanzmann’s thrombasthenia. J Clin Invest 1986; 78: 1103-11; PMID:2428841; http://dx.doi.org/10.1172/ JCI112667 37. Fitzgerald LA, Steiner B, Rall SC, Jr., Lo S, Phillips DR. Protein sequence of endothelial glycoprotein IIIa derived from a cDNA clone. Identity with platelet glycoprotein IIIa and similarity to “integrin”. J Biol Chem 1987; 262:3936-9; PMID:3494014 38. Staatz WD, Rajpara SM, Wayner EA, Carter WG, Santoro SA. The membrane glycoprotein Ia-IIa (VLA2) complex mediates the Mg2+-dependent adhesion of platelets to collagen. J Cell Biol 1989; 108:1917-24; PMID:2715183; http://dx.doi.org/10.1083/jcb.108.5. 1917 39. Dransfield I, Cabanas C, Craig A, Hogg N. Divalent cation regulation of the function of the leukocyte integrin LFA-1. J Cell Biol 1992; 116:219-26; PMID: 1346139; http://dx.doi.org/10.1083/jcb.116.1.219 40. Nieuwenhuizen W, Gravesen M. Anticoagulant and calcium-binding properties of high molecular weight derivatives of human fibrinogen, produced by plasmin (fragments X). Biochim Biophys Acta 1981; 668:81-8; PMID:6453618 41. Dransfield I, Cabañas C, Craig A, Hogg N. Divalent cation regulation of the function of the leukocyte integrin LFA-1. J Cell Biol 1992; 116:219-26; PMID: 1346139; http://dx.doi.org/10.1083/jcb.116.1.219 42. Hu DD, Hoyer JR, Smith JW. Ca2+ suppresses cell adhesion to osteopontin by attenuating binding affinity for integrin aVβ3. J Biol Chem 1995; 270:991725; PMID:7537271; http://dx.doi.org/10.1074/jbc. 270.17.9917 43. van Kooyk Y, Weder P, Heije K, De Waal Malefijt R, Figdor CG. Role of intracellular Ca2+ levels in the regulation of CD11a/CD18 mediated cell adhesion. Cell Adhes Commun 1993; 1:21-32; PMID:7915956; http://dx.doi.org/10.3109/15419069309095679 44. Onley DJ, Knight CG, Tuckwell DS, Barnes MJ, Farndale RW. Micromolar Ca2+ concentrations are essential for Mg2+-dependent binding of collagen by the integrin a2β1 in human platelets. J Biol Chem 2000; 275:24560-4; PMID:10827198; http://dx.doi. org/10.1074/jbc.M004111200 45. Labadia ME, Jeanfavre DD, Caviness GO, Morelock MM. Molecular regulation of the interaction between leukocyte function-associated antigen-1 and soluble ICAM-1 by divalent metal cations. J Immunol 1998; 161:836-42; PMID:9670961

46. Leitinger B, McDowall A, Stanley P, Hogg N. The regulation of integrin function by Ca2+. Biochim Biophys Acta 2000; 1498:91-8; PMID:11108953; http://dx.doi.org/10.1016/S0167-4889(00)00086-0 47. Humphries MJ. Integrin activation: The link between ligand binding and signal transduction. Curr Opin Cell Biol 1996; 8:632-40; PMID:8939662; http://dx. doi.org/10.1016/S0955-0674(96)80104-9 48. Cierniewski CSHT, Smith JW, Plow EF. Characterization of cation-binding sequences in the platelet integrin GPIIb-IIIa (aIIbβ3) by terbium luminescence. Biochemistry 1994; 33:12238-46; PMID:7522557; http://dx.doi.org/10.1021/bi00206a029 49. Rivas GA, Gonzalez-Rodriguez J. Calcium binding to human platelet integrin GPIIb/IIIa and to its constituent glycoproteins: Effects of lipids and temperature. Biochem J 1991; 276:35-40; PMID:2039481 50. Cierniewska-Cieslak A, Cierniewski CS, Blecka K, Papierak M, Michalec L, Zhang L, et al. Identification and characterization of two cation binding sites in the integrin β3 subunit. J Biol Chem 2002; 277:1112634; PMID:11796735; http://dx.doi.org/10.1074/jbc. M112388200 51. Chen LL, Whitty A, Scott D, Lee WC, Cornebise M, Adams SP, et al. Evidence that ligand and metal ion binding to integrin a4β1 are regulated through a coupled equilibrium. J Biol Chem 2001; 276:36520-9; PMID:11473127; http://dx.doi.org/10.1074/jbc. M106216200 52. Mitchell WB, Li JH, Singh F, Michelson AD, Bussel J, Coller BS, et al. Two novel mutations in the aIIb calcium-binding domains identify hydrophobic regions essential for aIIbβ3 biogenesis. Blood 2003; 101: 2268-76; PMID:12424194; http://dx.doi.org/10. 1182/blood-2002-07-2266 53. Tuckwell DS, Brass A, Humphries MJ. Homology modelling of integrin EF-hands. Evidence for widespread use of a conserved cation-binding site. Biochem J 1992; 285:325-31; PMID:1322124 54. Springer TA, Jing H, Takagi J. A novel Ca2+ binding beta hairpin loop better resembles integrin sequence motifs than the EF hand. Cell 2000; 102:275-7; PMID:10975518; http://dx.doi.org/10.1016/S00928674(00)00033-7 55. Springer TA. Folding of the N-terminal, ligandbinding region of integrin a-subunits into a betapropeller domain. Proc Natl Acad Sci USA 1997; 94:65-72; PMID:8990162; http://dx.doi.org/10. 1073/pnas.94.1.65 56. D’Souza SE, Ginsberg MH, Matsueda GR, Plow EF. A discrete sequence in a platelet integrin is involved in ligand recognition. Nature 1991; 350:66-8; PMID: 2002847; http://dx.doi.org/10.1038/350066a0 57. Gulino D, Boudignon C, Zhang L, Concord E, Rabiet M-J, Marguerie G. Ca2+-binding properties of the platelet glycoprotein IIb ligand-interacting domain. J Biol Chem 1992; 267:1001-7; PMID:1730629 58. Loftus JC, Halloran CE, Ginsberg MH, Feigen LP, Zablocki JA, Smith JW. The amino-terminal one-third of aIIb defines the ligand recognition specificity of integrin aIIbβ3. J Biol Chem 1996; 271:2033-9; PMID:8567656; http://dx.doi.org/10.1074/jbc.271.4. 2033 59. Masumoto A, Hemler ME. Mutation of putative divalent cation sites in the a4 subunit of the integrin VLA-4; distinct effects on adhesion to CS1/fibronectin, VCAM-1, and invasin. J Cell Biol 1993; 123:24553; PMID:7691827; http://dx.doi.org/10.1083/jcb. 123.1.245 60. Poncz M, Rifat S, Coller BS, Newman PJ, Shattil SJ, Parrella T, et al. Glanzmann thrombasthenia secondary to a Gly273 - Asp mutation adjacent to the first calcium-binding domain of platelet glycoprotein IIb. J Clin Invest 1994; 93:172-9; PMID:8282784; http:// dx.doi.org/10.1172/JCI116942

61. Wilcox DA, Wautier JL, Pidard D, Newman PJ. A single amino acid substitution flanking the fourth calcium binding domain of aIIb prevents maturation of the aIIbβ3 integrin complex. J Biol Chem 1994; 269:4450-7; PMID:7508443 62. Wilcox DA, Paddock CM, Lyman S, Gill JC, Newman PJ. Glanzmann thrombasthenia resulting from a single amino acid substitution between the second and third calcium-binding domains of GPIIb. J Clin Invest 1995; 95:1553-60; PMID:7706461; http://dx.doi.org/10.1172/JCI117828 63. Basani RB, Vilaire G, Shattil SJ, Kolodziej MA, Bennett JS, Poncz M. Glanzmann thrombasthenia due to a two amino acid deletion in the fourth calciumbinding domain of aIIb: demonstration of the importance of calcium-binding domains in the conformation of aIIbβ3. Blood 1996; 88:167-73; PMID:8704171 64. Ferrer M, Fernandez-Pinel M, Gonzalez-Manchon C, Gonzalez J, Ayuso MS, Parrilla R. A mutant (Arg327→His) GPIIb associated to thrombasthenia exerts a dominant negative effect in stably transfected CHO cells. Thromb Haemost 1996; 76:292-301; PMID:8883261 65. Xie C, Shimaoka M, Xiao T, Schwab P, Klickstein LB, Springer TA. The integrin a subunit leg extends at a Ca2+-dependent epitope in the thigh/genu interface upon activation. Proc Natl Acad Sci USA 2004; 101:15422-7; PMID:15494438; http://dx.doi.org/10. 1073/pnas.0406680101 66. Diamond MS, Garcia-Aguilar J, Bickford JK, Corbi AL, Springer TA. The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands. J Cell Biol 1993; 120:1031-43; PMID:7679388; http://dx.doi.org/10. 1083/jcb.120.4.1031 67. Michishita M, Videm V, Arnaout MA. A novel divalent cation-binding site in the A domain of the β2 integrin CR3 (CD11b/CD18) is essential for ligand binding. Cell 1993; 72:857-67; PMID:8458080; http://dx.doi.org/10.1016/0092-8674(93)90575-B 68. Shimaoka M, Xiao T, Liu JH, Yang Y, Dong Y, Jun CD, et al. Structures of the aL I domain and its complex with ICAM-1 reveal a shape-shifting pathway for integrin regulation. Cell 2003; 112:99-111; PMID:12526797; http://dx.doi.org/10.1016/S00928674(02)01257-6 69. Song G, Yang Y, Liu JH, Casasnovas JM, Shimaoka M, Springer TA, et al. An atomic resolution view of ICAM recognition in a complex between the binding domains of ICAM-3 and integrin aLβ2. Proc Natl Acad Sci USA 2005; 102:3366-71; PMID:15728350; http://dx.doi.org/10.1073/pnas.0500200102 70. Lee JO, Rieu P, Arnaout MA, Liddington R. Crystal structure of the A domain from the a subunit of integrin CR3 (CD11b/CD18). Cell 1995; 80:631-8; PMID:7867070; http://dx.doi.org/10.1016/00928674(95)90517-0 71. Emsley J, Knight CG, Farndale RW, Barnes MJ, Liddington RC. Structural basis of collagen recognition by integrin a2β1. Cell 2000; 101:47-56; PMID:10778855; http://dx.doi.org/10.1016/S00928674(00)80622-4 72. Lee J-O, Bankston LA, Arnaout MA, Liddington RC. Two conformations of the integrin A-domain (Idomain): a pathway for activation? Structure 1995; 3:1333-40; PMID:8747460; http://dx.doi.org/10. 1016/S0969-2126(01)00271-4 73. Xiong JP, Stehle T, Zhang R, Joachimiak A, Frech M, Goodman SL, et al. Crystal structure of the extracellular segment of integrin aVβ3 in complex with an Arg-Gly-Asp ligand. Science 2002; 296:151-5; PMID:11884718; http://dx.doi.org/10.1126/science. 1069040


28


Volume 6 Issue 1

74. Xiong J-P, Li R, Essafi M, Stehle T, Arnaout MA. An isoleucine-based allosteric switch controls affinity and shape shifting in integrin CD11b A-domain. J Biol Chem 2000; 275:38762-7; PMID:11034990; http:// dx.doi.org/10.1074/jbc.C000563200 75. Hu DD, Barbas CF, Smith JW. An allosteric Ca2+ binding site on the β3-integrins that regulates the dissociation rate for RGD ligands. J Biol Chem 1996; 271:21745-51; PMID:8702970; http://dx.doi.org/10. 1074/jbc.271.36.21745 76. Takagi J, Strokovich K, Springer TA, Walz T. Structure of integrin a5β1 in complex with fibronectin. EMBO J 2003; 22:4607-15; PMID:12970173; http://dx.doi.org/10.1093/emboj/cdg445 77. Xiao T, Takagi J, Wang J-h, Coller BS, Springer TA. Structural basis for allostery in integrins and binding of ligand-mimetic therapeutics to the platelet receptor for fibrinogen. Nature 2004; 432:59-67; PMID: 15378069; http://dx.doi.org/10.1038/nature02976 78. Raborn J, Wang W, Luo BH. Regulation of integrin aIIbβ3 ligand binding and signaling by the metal ion binding sites in the β I domain. Biochemistry 2011; 50:2084-91; PMID:21309594; http://dx.doi.org/10. 1021/bi2000092 79. Chen J, Salas A, Springer TA. Bistable regulation of integrin adhesiveness by a bipolar metal ion cluster. Nat Struct Biol 2003; 10:995-1001; PMID: 14608374; http://dx.doi.org/10.1038/nsb1011 80. Chen J, Takagi J, Xie C, Xiao T, Luo BH, Springer TA. The relative influence of metal ion binding sites in the I-like domain and the interface with the hybrid domain on rolling and firm adhesion by integrin a4β7. J Biol Chem 2004; 279:55556-61; PMID:15448154; http://dx.doi.org/10.1074/jbc.M407773200 81. Mould AP, Barton SJ, Askari JA, Craig SE, Humphries MJ. Role of ADMIDAS cation-binding site in ligand recognition by integrin a5β1. J Biol Chem 2003; 278:51622-9; PMID:14532288; http://dx.doi.org/10. 1074/jbc.M306655200 82. Whittaker CA, Hynes RO. Essay from the Genome Annotation Series: Distribution and Evolution of the von Willebrand/Integrin A domain: a widely dispersed domain with roles in cell adhesion and elsewhere. Mol Biol Cell 2002; 13:3369-87; PMID:12388743; http:// dx.doi.org/10.1091/mbc.E02-05-0259 83. Hynes RO, Zhao Q. The evolution of cell adhesion. J Cell Biol 2000; 150:F89-96; PMID:10908592; http:// dx.doi.org/10.1083/jcb.150.2.F89 84. Shimaoka M, Takagi J, Springer TA. Conformational regulation of integrin structure and function. Annu Rev Biophys Biomol Struct 2002; 31:485-516; PMID:11988479; http://dx.doi.org/10.1146/annurev. biophys.31.101101.140922

85. Huth JR, Olejniczak ET, Mendoza R, Liang H, Harris EA, Lupher ML, Jr., et al. NMR and mutagenesis evidence for an I domain allosteric site that regulates lymphocyte function-associated antigen 1 ligand binding. Proc Natl Acad Sci USA 2000; 97:5231-6; PMID:10805782; http://dx.doi.org/10.1073/pnas.97. 10.5231 86. Alonso JL, Essafi M, Xiong JP, Stehle T, Arnaout MA. Does the integrin aA domain act as a ligand for its βA domain? Curr Biol 2002; 12:R340-2; PMID: 12015130; http://dx.doi.org/10.1016/S0960-9822 (02)00852-7 87. Yang W, Shimaoka M, Salas A, Takagi J, Springer TA. Intersubunit signal transmission in integrins by a receptor-like interaction with a pull spring. Proc Natl Acad Sci USA 2004; 101:2906-11; PMID:14978279; http://dx.doi.org/10.1073/pnas.0307340101 88. Harding MM. Geometry of metal-ligand interactions in proteins. Acta Crystallogr D Biol Crystallogr 2001; 57:401-11; PMID:11223517; http://dx.doi.org/10. 1107/S0907444900019168 89. McEver RP, Zhu C. Rolling cell adhesion. Annu Rev Cell Dev Biol 2010; 26:363-96; PMID:19575676; http://dx.doi.org/10.1146/annurev.cellbio.042308. 113238 90. Bajt ML, Loftus JC. Mutation of a ligand binding domain of β3 integrin: integral role of oxygenated residues in aIIbβ3 (GPIIb-IIIa) receptor function. J Biol Chem 1994; 269:20913-9; PMID:7520434 91. Chen J, Yang W, Kim M, Carman CV, Springer TA. Regulation of outside-in signaling and affinity by the β2 I domain of integrin aLβ2. Proc Natl Acad Sci USA 2006; 103:13062-7; PMID:16920795; http://dx.doi. org/10.1073/pnas.0605666103 92. Park EJ, Mora JR, Carman CV, Chen J, Sasaki Y, Cheng G, et al. Aberrant activation of integrin a4β7 suppresses lymphocyte migration to the gut. J Clin Invest 2007; 117:2526-38; PMID:17786243; http:// dx.doi.org/10.1172/JCI31570 93. Murcia M, Jirouskova M, Li J, Coller BS, Filizola M. Functional and computational studies of the ligandassociated metal binding site of β3 integrins. Proteins 2008; 71:1779-91; PMID:18175315; http://dx.doi. org/10.1002/prot.21859 94. Tozer EC, Liddington RC, Sutcliffe MJ, Smeeton AH, Loftus JC. Ligand binding to integrin aIIbβ3 is dependent on a MIDAS-like domain in the β3 subunit. J Biol Chem 1996; 271:21978-84; PMID: 8703003; http://dx.doi.org/10.1074/jbc.271.36.21978 95. Yamanouchi J, Hato T, Tamura T, Fujita S. Identification of critical residues for ligand binding in the integrin β3 I-domain by site-directed mutagenesis. Thromb Haemost 2002; 87:756-62; PMID:12008962

96. Baker EK, Tozer EC, Pfaff M, Shattil SJ, Loftus JC, Ginsberg MH. A genetic analysis of integrin function: Glanzmann thrombasthenia in vitro.. Proc Natl Acad Sci USA 1997; 94:1973-8; PMID:9050889; http://dx. doi.org/10.1073/pnas.94.5.1973 97. Pan Y, Zhang K, Qi J, Yue J, Springer TA, Chen J. Cation-p interaction regulates ligand-binding affinity and signaling of integrin a4β7. Proc Natl Acad Sci USA 2010; 107:21388-93; PMID:21098296; http:// dx.doi.org/10.1073/pnas.1015487107 98. Kamata T, Tieu KK, Tarui T, Puzon-McLaughlin W, Hogg N, Takada Y. The role of the CPNKEKEC sequence in the β2 subunit I domain in regulation of integrin aLβ2 (LFA-1). J Immunol 2002; 168:2296301; PMID:11859118 99. Salas A, Shimaoka M, Kogan AN, Harwood C, von Andrian UH, Springer TA. Rolling adhesion through an extended conformation of integrin aLβ2 and relation to a I and β I-like domain interaction. Immunity 2004; 20:393-406; PMID:15084269; http://dx.doi.org/10.1016/S1074-7613(04)00082-2 100. Marlin SD, Springer TA. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell 1987; 51: 813-9; PMID:3315233; http://dx.doi.org/10.1016/ 0092-8674(87)90104-8 101. Mould AP, Akiyama SK, Humphries MJ. Regulation of integrin a5β 1-fibronectin interactions by divalent cations. Evidence for distinct classes of binding sites for Mn2+, Mg2+, and Ca2+. J Biol Chem 1995; 270:26270-7; PMID:7592835 102. Burrows L, Clark K, Mould AP, Humphries MJ. Fine mapping of inhibitory anti-a5 monoclonal antibody epitopes that differentially affect integrin-ligand binding. Biochem J 1999; 344:527-33; PMID:10567237; http://dx.doi.org/10.1042/0264-6021:3440527 103. Mould AP, Symonds EJ, Buckley PA, Grossmann JG, McEwan PA, Barton SJ, et al. Structure of an integrinligand complex deduced from solution X-ray scattering and site-directed mutagenesis. J Biol Chem 2003; 278:39993-9; PMID:12871973; http://dx.doi.org/10. 1074/jbc.M304627200 104. Pesho MM, Bledzka K, Michalec L, Cierniewski CS, Plow EF. The specificity and function of the metalbinding sites in the integrin β3 A-domain. J Biol Chem 2006; 281:23034-41; PMID:16723352; http://dx.doi. org/10.1074/jbc.M602856200 105. Grzesiak JJ, Pierschbacher MD. Changes in the concentrations of extracellular Mg2+ and Ca2+ down-regulate E-cadherin and up-regulate a2β1 integrin function, activating keratinocyte migration on type I collagen. J Invest Dermatol 1995; 104:768-74; PMID:7537775; http://dx.doi.org/10.1111/1523-1747.ep12606983




29